What Is Collagen Type III and What Does It Do?

Collagen type III is a fibrillar protein found throughout tissues that need to stretch and recoil, including skin, blood vessel walls, and the lining of internal organs. It is one of the most abundant collagens in the human body, and its main job is to provide elastic resilience: the ability of a tissue to deform under pressure and then snap back to its original shape. While collagen type I gets most of the attention in supplement marketing and skincare, type III works alongside it in nearly every connective tissue, and losing it or having a defective version leads to consequences that range from fragile skin to life-threatening arterial rupture.

How Type III Collagen Is Built

The protein is encoded by a single gene called COL3A1. Three identical protein chains, each called an alpha-1(III) chain, wind around one another to form a long, rope-like triple helix. That triple helix is the functional unit of type III collagen and is responsible for its mechanical properties.¹ The triple-helical region contains repeated sequences of three amino acids, always starting with glycine. Charged amino acid clusters within these repeats create strong hydrogen bonds between the three chains and between neighboring helices, which helps the molecule maintain its structure while also allowing some flexibility.²

Assembly happens in a specific order. The process begins at the tail end of the molecule, where the folded carboxyl propeptides of each chain recognize one another and bond through disulfide bridges. Once those tails lock together, the triple helix zips up from that anchor point toward the other end of the molecule, and then disulfide bonds form between the amino propeptides at the top.³ The initial product, called procollagen, is secreted outside the cell, where enzymes trim off those propeptide extensions. That trimming step is relevant later, because the fragments left behind are used as blood biomarkers to track how much type III collagen the body is making or destroying.

Where You Find It and What It Does There

Type III collagen concentrates in tissues that need to be compliant and elastic rather than rigid. Skin, the walls of arteries and veins, the gut, the uterus, and the lungs are all rich in it.⁴ In the heart, the structural protein scaffold is made mostly of collagen types I and III. Type I is stiff and provides tensile strength, resisting stretching. Type III, by contrast, forms an elastic network that stores kinetic energy and releases it as an elastic rebound, much like a rubber band.⁵ This division of labor matters everywhere the two collagens coexist: type I resists pulling forces, and type III lets the tissue give and recover.

In practical terms, a blood vessel wall that pumps blood at 60 to 100 beats per minute needs to expand with each heartbeat and shrink back afterward. The type III collagen in that wall is a major reason it can do so without tearing. Similar logic applies to the lungs, which inflate and deflate thousands of times per day, and to the intestines, which contract rhythmically to move food along.

Type III Collagen in Skin and Aging

Skin contains both type I and type III collagen, and the ratio between them shifts over a lifetime. In embryonic and fetal skin, type III collagen makes up roughly 18 to 21% of total collagen, while type I accounts for about 70 to 75%.⁶ By adulthood, the type III share drops to about 8 to 11%, and type I rises to 85 to 90%. So young skin is comparatively richer in type III collagen, which may partly explain why children’s skin feels softer and more pliable.

What happens in old age is less intuitive. A study examining skin from people across a range of ages found that the proportion of type III collagen in sun-protected skin stayed relatively stable through childhood and young adulthood, then actually increased in elderly individuals to a variable degree.⁷ That might sound like good news, but the total amount of collagen in aged skin declines substantially. The rising proportion of type III likely reflects the loss of type I more than a genuine gain in type III. The net effect is still thinner, weaker skin.

Its Role in Blood Clotting

When a blood vessel is injured and the inner lining tears, the collagen underneath becomes exposed to flowing blood. Platelets, the cell fragments responsible for forming a clot, recognize and stick to that collagen. Type III collagen is one of the key triggers for this process. Experiments exposing pure type III collagen to flowing human blood showed that platelets rapidly adhered and formed clots, with surface coverage reaching up to about 59% at high flow rates.⁸

Researchers have mapped specific regions on the type III collagen molecule that trigger platelet clumping. One peptide fragment called alpha-1(III)CB4 is particularly potent at aggregating platelets and is structurally very similar to a platelet-reactive site on type I collagen.⁹ Interestingly, the two collagen types use somewhat different receptor pathways on the platelet surface. A receptor called glycoprotein Ia/IIa is critical for platelets to adhere to type I collagen but plays a much smaller role in the platelet response to type III collagen, suggesting the body has parallel but distinct clotting mechanisms depending on which collagen is exposed.¹⁰

Wound Healing and Tissue Repair

Type III collagen plays an outsized role during the early phase of wound repair. When tissue is damaged, the body initially lays down a provisional matrix rich in type III collagen. Over weeks and months, this softer scaffold is gradually replaced by the stiffer type I collagen, producing a mature scar. This transition is part of why fresh scars feel soft and older scars feel harder. The balance between type I and type III collagen production after injury affects how flexible or rigid the healed tissue ends up being, and tipping too far toward type I can produce excessive scarring.

In the heart, the same pair of collagens maintains the structural framework around muscle cells. After a heart attack, the damaged area undergoes a similar remodeling process, initially depositing type III collagen and then shifting toward type I. The ratio matters for cardiac function: too much stiff type I relative to elastic type III can impair the heart’s ability to relax between beats.⁵

Lungs and Mechanical Stress

Because the lungs continuously stretch and contract, they rely heavily on type III collagen for structural compliance. Studies on lung tissue show that mechanical force, specifically the stress applied to lung tissue rather than the amplitude of the stretch, stimulates cells to ramp up production of type III procollagen messenger RNA.¹¹ In other words, the lungs have a built-in feedback mechanism: when they experience more force, they make more of the elastic collagen that lets them handle that force.

This system can go wrong in chronic obstructive pulmonary disease (COPD). In the large airways of people with severe COPD, expression of the type I collagen precursor drops while the type III precursor increases. In smaller airways, the pattern reverses in advanced disease: type III collagen precursor expression falls.¹² These uneven shifts may contribute to airway remodeling and the progressive loss of lung function that defines COPD. The lungs essentially lose their ability to maintain the right ratio of stiff-to-elastic collagen, and the tissue changes shape in ways that trap air and make breathing harder.

How the Body Breaks It Down

Collagen turnover is constant. The enzymes primarily responsible for degrading type III collagen belong to a family called matrix metalloproteinases, or MMPs. MMP-9 can cleave native type III collagen at a characteristic three-quarter/one-quarter site, the same kind of cut that the classic collagenase MMP-1 makes.¹³ This matters because elevated MMP-9 activity shows up in conditions where tissue is being actively remodeled or destroyed, from liver disease to tumor invasion.

In liver fibrosis, the balance between collagen production and degradation goes haywire. Specialized cells in the liver called hepatic stellate cells start overproducing types I and III collagen when the liver is injured repeatedly, whether by alcohol, viruses, or toxins. The excess collagen accumulates, stiffening the liver and impeding blood flow through it.¹⁴ Researchers have developed blood tests that detect specific MMP-9-cleaved fragments of type III collagen as a way to gauge how actively the liver is scarring without needing a biopsy.¹⁵

PIIINP as a Blood Biomarker

When procollagen type III is processed into mature collagen, the trimmed-off amino-terminal propeptide fragment, called PIIINP, enters the bloodstream. Measuring PIIINP in a blood sample gives clinicians a snapshot of how much type III collagen turnover is happening in the body. It has been used for years to monitor liver fibrosis in patients on methotrexate, a drug that can damage the liver over time.¹⁶

More recently, PIIINP has attracted interest as a cardiovascular marker. In healthy young adults, higher PIIINP levels correlate with increased thickness of the carotid artery wall, a preclinical sign of cardiovascular risk. Because a blood draw is simpler and less dependent on the skill of the person performing the test than an ultrasound measurement of artery thickness, researchers have suggested PIIINP could serve as an early screening tool for cardiovascular disease.¹⁷

In pulmonary arterial hypertension, PIIINP levels are elevated compared to healthy controls and rise further as the disease worsens. Higher PIIINP tracked with shorter walking distance, lower cardiac output, and more advanced functional class.¹⁸ So a simple blood marker originally developed for liver monitoring turns out to offer a window into how actively the body is remodeling collagen in the lungs and blood vessels as well.

What Happens When Type III Collagen Is Defective

The most dramatic illustration of type III collagen’s importance comes from vascular Ehlers-Danlos syndrome (vEDS), a genetic disorder caused by mutations in the COL3A1 gene. People with vEDS produce abnormal type III collagen, leaving their blood vessel walls, intestinal walls, and uterus dangerously fragile. The hallmark features include thin, translucent skin and a tendency toward spontaneous arterial, intestinal, and uterine rupture.⁴

The genetics are heterogeneous. A large study of families with vEDS identified over 410 different causative mutations in COL3A1. The most common category, accounting for roughly 356 of 572 index cases, involved substitutions for glycine in the repeating Gly-X-Y pattern of the triple helix. Disruption of the glycine at any of those positions destabilizes the entire triple-helix structure. Another 164 cases had splicing mutations, and 27 had null mutations that simply eliminated stable messenger RNA from one copy of the gene.¹⁹ The type of mutation influences severity and survival, with glycine substitutions in the triple-helical domain generally being more dangerous than null mutations, because a misfolded chain poisons the entire three-chain molecule rather than simply reducing the total amount of collagen produced.

In the colon, vEDS produces distinctive pathological changes: abrupt shifts in the thickness of the muscular wall, secondary diverticula, and greatly reduced expression of abnormal collagen 3. These findings can help pathologists identify the condition in patients who experience spontaneous bowel perforation, particularly in younger people where such an event is otherwise rare.²⁰

Cervical Remodeling During Pregnancy

The cervix is another tissue where type III collagen plays a structural role with high-stakes consequences. During pregnancy, the cervix must soften progressively to allow delivery. This softening involves cumulative changes in the extracellular matrix, including reorganization of collagen fibrils and a gradual loss of tensile strength that begins early in pregnancy. The total amount of collagen remains roughly constant; instead, the types of cross-links holding the collagen network together change, and expression of certain matrix-organizing proteins drops.²¹ When this process happens prematurely, it can contribute to cervical insufficiency and preterm birth. Researchers studying cervical remodeling have focused heavily on the interplay between collagen types I and III, and how cross-link chemistry determines whether the tissue holds firm or gives way.

Can You Boost Type III Collagen Through Diet or Supplements?

The collagen supplement industry is enormous, but most products market themselves generically as “collagen” without specifying which type they contain. Most commercial collagen supplements are derived from bovine hides or fish scales and consist largely of type I collagen. Whether oral collagen intake actually reaches target tissues and stimulates your body to produce more of its own collagen, including type III, is a question the research is still sorting out.

Animal studies offer some encouraging signals. Aged rats given marine collagen hydrolysate orally over an extended period showed increased protein expression of both type I and type III collagen in their skin compared to untreated aged controls. The mechanism appeared to involve activation of a signaling pathway (TGF-beta/Smad) that upregulates procollagen gene expression for both types.²² Whether this translates to meaningful skin improvements in humans at standard supplement doses is less clear. Human trials of collagen supplements tend to measure outcomes like skin elasticity and wrinkle depth rather than directly measuring type III collagen levels in tissue, so the specific effect on type III remains somewhat speculative.

Beyond supplements, vitamin C is an essential cofactor for the enzymes that stabilize all collagen triple helices after they are made, including type III. A severe deficiency causes scurvy, where collagen literally falls apart throughout the body. Adequate vitamin C intake is a prerequisite for healthy collagen production, but loading up on extra vitamin C beyond normal levels does not appear to supercharge collagen synthesis.

Gene Therapy Approaches for Vascular Ehlers-Danlos Syndrome

Because vEDS is caused by a single gene and because the dominant-negative mechanism means that one bad copy of COL3A1 poisons molecules containing the good chain too, researchers have been exploring whether you can selectively silence just the mutant copy of the gene. The approach uses small interfering RNAs designed to recognize the specific mutation in a patient’s COL3A1 gene. In laboratory experiments with fibroblasts from vEDS patients, the best-performing siRNA achieved over 90% silencing of the mutant allele without affecting the normal one.²³

This selective silencing improved collagen fibril formation in treated cells and reduced the damaging effects of misfolded proteins accumulating inside them.²⁴ The concept is appealing because it is truly personalized: the siRNA is tailored to the individual’s exact mutation. The catch is that with over 400 known mutations in COL3A1, each patient may need a custom-designed therapy, and none of this work has yet moved beyond cell culture into human clinical trials. Delivery to the vascular endothelium and smooth muscle cells that need it most remains a major unsolved challenge. Still, the proof of concept is strong enough that it ranks among the more promising avenues for a condition that currently has no cure and is managed primarily by avoiding physical trauma and screening for vascular complications.